ArticleBMC medical imaging2025
Exploring the associations between features from multi-parametric MR images in Glioblastoma using radiomics.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evaluating sequence contributions to MRI radiomics for glioblastoma survival: single vs fusion models.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThis study aimed to analyze the associations and substitutability of multi-parametric MRI images in glioblastoma (Gb) using the radiomics method.
methodsUtilizing the University of Pennsylvania Health System Glioblastoma dataset from The Cancer Imaging Archive, we extracted quantitative features from T1-weighted, T2-weighted, T2 fluid attenuated inversion recovery (T2-FLAIR), and post-contrast T1-weighted (T1-Gd) images. Feature associations were assessed using Spearman rank correlation with Benjamini-Hochberg correction for multiple comparisons. The substitution analysis was subsequently performed by developing prognostic signatures based on individual MRI sequences and then evaluating the performance of substituted signatures, wherein features from one sequence were replaced by their counterparts from another. Discriminative power was evaluated by the area under the receiver-operating-characteristic curve (AUC).
resultsSignificant feature associations were observed across different MRI sequences. The strongest correlation was identified between T2-weighted and T2-FLAIR images, where 93% of features were significantly and positively correlated (mean absolute correlation coefficient [CC]: 0.57 ± 0.21). A substantial association was also noted between T1-weighted and T1-Gd images, with 86% of features significantly correlated (mean absolute CC: 0.49 ± 0.23). The correlation between T2-weighted and T1-Gd images was less pronounced (75% of features; mean absolute CC: 0.44). In the substitution analysis for prognostication, a signature based on T1-weighted images achieved an AUC of 0.73 (95% CI, 0.60-0.84). Replacing its features with those from T2-weighted images resulted in a signature with a slightly lower AUC of 0.65 (95% CI, 0.51-0.77), a modest difference of 0.08 (95% CI, -0.05-0.21). Conversely, substituting features from a T2-weighted image-based signature with their T1-Gd counterparts resulted in a more substantial decrease in AUC (difference: 0.10, 95% CI, -0.05-0.25).
conclusionsOur radiomics analysis indicated potential substantial information redundancy among certain multi-parametric MRI sequences for Gb characterization, particularly between T2-weighted and T2-FLAIR images. Nevertheless, sequences providing unique pathophysiological contrast, such as T1-Gd, appeared to hold distinct prognostic value that was not substituted. While these findings suggested the feasibility of abbreviated multi-parametric MR protocols for specific radiomics applications, they simultaneously underscored that rigorous, task-specific validation was an indispensable prerequisite for any consideration of widespread clinical adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.